Franchise Global Reports Record First Quarter 2022 Financial Results; Revenues Increased by $16.2 Million YoY to $16.6 Million
ABOUT US
Franchise Global Health is a fully integrated medical cannabis company focused on building industry-leading, European-focused medical cannabis operations with an expertise in genetics, cultivation, and pharma distribution.
Franchise has an early mover advantage in the European market after receiving the first import and distribution license in Germany and will leverage this expertise to achieve profitable growth and build sustainable, long-term shareholder value.
Our People
A Message from Our CEO, Clifford Starke
OUR BUSINESS
| GENETICS | Franchise’s portfolio includes 286 highly sought out strains. Europe’s 1st legal and registered seed bank. |
 |
| Cultivation | 500,000 sq. ft reserved cultivation capacity at an EU GMP certified facility in Ontario, Canada that has delivered to Germany in addition to numerous low-cost, long term strategic cultivation assets in the pipeline. |
 |
| Processing | State of the art 30,000 sq. ft EU-GMP facility located in Ontario, Canada and a 90,000 sq. ft EU-GMP facility in Germany. |
 |
| Distribution | Franchise Global Health’s subsidiaries are well established pharmaceutical wholesalers & distributors with a strong network of over 1,200 German pharmacies for cannabis sales with pharma distribution relationships across 18 countries. |
 |
| Strategic Investments | Management has expertise and a track record of making accretive acquisitions in the highly competitive global cannabis market. |
 |
GLOBAL FOOTPRINT
WHY INVEST ?
|
Top 5 Reasons to Invest in
|
1. RBC Capital Markets: Miehm, D., & Oliphant , M. (2020). Extractor Industry Primer: Providing the Foundation for Cannabis Rec 2.0. RBC Dominion Securities Inc.
2. Brightfield Group, Hanway Associates. (2020). Succeeding in European Cannabis Fall 2020 Report. Chicago: Brightfield Group.